Dublin, May 12, 2026 (GLOBE NEWSWIRE) — The “Nucleic Acid Isolation and Purification Market by Product, Method, Type, Application, End User, Region – Global Forecast to 2030” has been added to ResearchAndMarkets.com’s offering.
The nucleic acid isolation and purification market is poised for significant growth, projected to expand from USD 7.10 billion in 2025 to USD 10.99 billion by 2030, at a CAGR of 9.1% during the forecast period. This uptrend is fueled by the increasing use of PCR and other NAAT workflows in infectious disease programs and the expanding application of NGS in clinical scenarios, necessitating high-quality DNA/RNA at the outset.
The magnetic-bead based isolation and purification segment accounted for the largest share, by method, in 2024
The market is segmented into magnetic bead-based, column-based, and reagent-based isolation and purification, as well as other methods. In 2024, magnetic bead-based isolation led the market due to its compatibility with automation and high-throughput processing, which are crucial for hospitals, reference labs, and large research centers. Bead-based methods offer consistent yields and reproducibility, reducing the need for reruns and ensuring timely results.
The diagnostics segment was the largest application segment in 2024
The market is categorized by application into diagnostics, drug discovery and development, personalized medicine, agriculture, animal research, and other uses. In 2024, diagnostics was the leading application due to the essential role of DNA/RNA extraction in PCR/NAAT assays and the rising number of sequencing-based clinical tests. High routine volumes demanded by infectious disease panels, respiratory testing, and oncology molecular assays sustain this demand. Laboratories prioritize validated workflows to minimize variability and expedite processing times.
The Asia Pacific region is forecasted to grow at the highest CAGR from 2025 to 2030
This region is experiencing growth propelled by the expansion of population genomics programs and a burgeoning focus on precision medicine. There is an increased need for diagnosing and monitoring rare and genetic diseases, especially in countries with aging populations like Japan and China, leading to broader adoption of sequencing and molecular testing in healthcare.
Research Coverage
This research categorizes the nucleic acid isolation and purification market by product, type, method, application, end user, and region. It offers insights into key growth influences, challenges, and opportunities, along with an analysis of major industry players’ competitive strategies. The report provides detailed insights into market segmentation, regional growth, and stakeholder strategies.
List of Companies Profiled
- Thermo Fisher Scientific Inc. (US)
- Merck KGaA (Germany)
- QIAGEN (Germany)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Promega Corporation (US)
- Agilent Technologies, Inc. (US)
- Danaher (US)
- Bio-Rad Laboratories, Inc. (US)
- Illumina, Inc. (US)
- Takara Bio Inc. (Japan)
- New England Biolabs (US)
- Abcam Plc (UK)
- KILPEST India Limited (India)
- Apical Scientific Sdn. Bhd. (Malaysia)
- Endress+Hauser Group Services AG (Switzerland)
- GENAXXON bioscience GmbH (Germany)
- LGC Biosearch Technologies (US)
- Zymo Research Corporation (US)
- Norgen Biotek Corp. (Canada)
- Omega Bio-Tek, Inc. (US)
- FAVORGEN Biotech Corp. (China)
- TIANGEN Biotech (Beijing) Co., Ltd. (China)
- AutoGen Inc. (US)
- PCR Biosystems (UK)
- Biogenuix (India)
Key Attributes
| Report Attribute | Details |
| No. of Pages | 545 |
| Forecast Period | 2025-2030 |
| Estimated Market Value (USD) in 2025 | $7.1 Billion |
| Forecasted Market Value (USD) by 2030 | $10.99 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
Market Dynamics
- Drivers
- Rising Adoption of Automated Nucleic Acid Extraction Systems
- Increasing Need for High-Purity and Inhibitor-Free Nucleic Acid Recovery
- Broadening Use of Magnetic Bead-based Purification Chemistries
- Growth in Complex and Difficult Sample-Type Processing
- Challenges
- Pre-Analytical Variability That Affects Extraction Output
- Removal of Inhibitors and Contaminants from Difficult Matrices
- Standardization and Validation for Regulated or Sensitive Workflows
- Opportunities
- Premium Extraction Solutions for Low-Input and Cell-Free Nucleic Acids
- Expansion of Automated Benchtop and Mid-Throughput Extraction Platforms
- Workflow Integration with Quantitation, Tracking, and Digital Reporting
- Application-Specific Extraction Workflows in Biopharma and CGT
Company Profiles
- Thermo Fisher Scientific Inc.
- Qiagen N.V.
- Merck KGaA
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Promega Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- Takara Bio Inc.
- New England Biolabs
- A&A Biotechnology
- Revvity Inc.
- Bioneer Corporation
- Himedia Laboratories Private Limited
- Other Players
- Kilpest India Limited
- Apical Scientific Sdn. Bhd.
- Endress+Hauser Group Services AG
- Genaxxon Bioscience GmbH
- Lgc Biosearch Technologies
- Zymo Research Corporation
- Norgen Biotek Corp.
- Omega Bio-Tek, Inc.
- Favorgen Biotech Corporation
- Tiangen Biotech(Beijing) Co. Ltd.
- Autogen Inc.
- Pcr Biosystems
- Biogenuix
- Mp Biomedicals
- Nanjing Vazyme Biotech Co. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/j1x625
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Nucleic Acid Isolation and Purification Market
